Medications How proximity to substance use treatment programs affects opioid-related health outcomes 4 years ago
Medications Advances in the study of drugs to combat cognitive impairment in schizophrenia 4 years ago
Medications UroGen Pharma Announces Positive Results of UGN-101 from Pivotal Phase 3 OLYMPUS Trial for the Non-Surgical Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer (LG UTUC) 4 years ago